World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00000602
Date of registration: 27/10/1999
Primary sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Public title: Pediatric Hydroxyurea in Sickle Cell Anemia (PED HUG)
Scientific title:
Date of first enrolment: April 1994
Target sample size:
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00000602
Study type:  Interventional
Study design:  Primary Purpose: Treatment  
Countries of recruitment
Contacts
Key inclusion & exclusion criteria

Children with sickle cell disease and between the ages of five and eighteen years.



Age minimum: 1 Year
Age maximum: 18 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Anemia, Sickle Cell
Hematologic Diseases
Hemoglobinopathies
Intervention(s)
Drug: hydroxyurea
Primary Outcome(s)
Secondary Outcome(s)
Secondary ID(s)
315
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history